Presse
Innovationspreise 2023 NRW
Spin-Off betaSENSE zieht ins BioMedizinZentrum
Spin-Off betaSENSE zieht ins BioMedizinZentrum
Oberbürgermeister Thomas Eiskirch übergab die Schlüssel feierlich an Geschäftsführer Klaus Gerwert.
▶
Die große Angst vor dem Vergessen
Publikationen
Alzheimer’s & Dementia, 2022
Alzheimer’s & Dementia, 2022
Amyloid-beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years
▶
Annals of Clinical & Translational Neurology, 2021
Annals of Clinical & Translational Neurology, 2021
TDP-43 as structure-based biomarker in amyotrophic lateral sclerosis
▶
Alzheimer’s Research & Therapy, 2020
Alzheimer’s Research & Therapy, 2020
Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline
▶
